| Literature DB >> 30219066 |
Cyrille Ngoufack Tagousop1, Jean-de-Dieu Tamokou2, Steve Endeguele Ekom3, David Ngnokam4, Laurence Voutquenne-Nazabadioko5.
Abstract
BACKGROUND: The search for new antimicrobials should take into account drug resistance phenomenon. Medicinal plants are known as sources of potent antimicrobial compounds including flavonoids. The objective of this investigation was to evaluate the antimicrobial activities of flavonoid glycosides from Graptophyllum grandulosum, as well as to determine their mechanism of antibacterial action using lysis, leakage and osmotic stress assays.Entities:
Keywords: Acanthaceae; Antibacterial; Antifungal; Flavonoid glycosides; Graptophyllum glandulosum; Mode of action
Mesh:
Substances:
Year: 2018 PMID: 30219066 PMCID: PMC6139119 DOI: 10.1186/s12906-018-2321-7
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Fig. 1Chemical structures of flavonoids (1–5) isolated from n-BuOH extract of aerial parts of G. grandulosum Turill. 1:chrysoeriol-7-O-β-D-xyloside; 2:luteolin-7-O-β-D-apiofuranosyl-(1 → 2)-β-D-xylopyranoside; 3: chrysoeriol-7-O-β-D-apiofuranosyl-(1 → 2)-β-D-xylopyranoside; 4: chrysoeriol-7-O-α-L-rhamnopyranosyl-(1 → 6)-β-D-(4"-hydrogenosulfate) glucopyranoside; 5:Isorhamnetin-3-O-α-L-rhamnopyranosyl-(1 → 6)-β-D-glucopyranoside
Antimicrobial activities of extracts, isolated compounds and reference antimicrobial drugs
| Extracts/Compounds | Inhibition parameters | |||||||
|---|---|---|---|---|---|---|---|---|
| MeOH extract | MIC | 512 | 512 | 256 | 512 | 256 | > 2048 | > 2048 |
| MMC | 512 | 512 | 512 | 1024 | 512 | / | / | |
| MMC/MIC | 1 | 1 | 2 | 2 | 2 | / | / | |
| MIC | 256 | 256 | 128 | 128 | 128 | 2048 | 2048 | |
| MMC | 256 | 256 | 128 | 256 | 128 | > 2048 | > 2048 | |
| MMC/MIC | 1 | 1 | 1 | 2 | 1 | / | / | |
| EtOAc extract | MIC | 64 | 128 | 64 | 64 | 64 | 1024 | 512 |
| MMC | 128 | 128 | 64 | 64 | 64 | 1024 | 1024 | |
| MMC/MIC | 2 | 1 | 1 | 1 | 1 | 1 | 2 | |
| 1 | MIC | 16 | 8 | 8 | 8 | 4 | 32 | 8 |
| MMC | 16 | 8 | 16 | 8 | 8 | 64 | 8 | |
| MMC/MIC | 1 | 1 | 2 | 1 | 2 | 2 | 1 | |
| 2 | MIC | 16 | 16 | 8 | 8 | 4 | 64 | 16 |
| MMC | 32 | 16 | 16 | 8 | 8 | 64 | 32 | |
| MMC/MIC | 2 | 1 | 2 | 1 | 2 | 1 | 2 | |
| 3 | MIC | 32 | 64 | 32 | 32 | 8 | 32 | 16 |
| MMC | 64 | 128 | 32 | 64 | 16 | 32 | 16 | |
| MMC/MIC | 2 | 2 | 1 | 2 | 2 | 1 | 1 | |
| 4 | MIC | 8 | 8 | 8 | 8 | 4 | 8 | 4 |
| MMC | 16 | 8 | 8 | 8 | 4 | 8 | 8 | |
| MMC/MIC | 2 | 1 | 1 | 1 | 1 | 1 | 2 | |
| 5 | MIC | 32 | 16 | 16 | 16 | 8 | 64 | 32 |
| MMC | 32 | 16 | 16 | 16 | 8 | 128 | 64 | |
| MMC/MIC | 1 | 1 | 1 | 1 | 1 | 2 | 2 | |
| Refa | MIC | 32 | 4 | 16 | 16 | 0.5 | 0.5 | 0.25 |
| MBC | 32 | 4 | 16 | 16 | 0.5 | 0.5 | 0.25 | |
| MBC/MIC | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
/: not determined; MIC Minimum Inhibitory Concentration, MMC Minimum Microbicidal Concentration; the MIC and MMC were measured in μg/mL; a: amphotericin B for yeasts and ciprofloxacin for bacteria
Antibacterial activities in terms of MIC (μg/mL) of compounds 1, 3 and 4 under osmotic stress condition against bacterial strains
| Bacteria | Compound 1 | Compound 2 | Compound 4 | Chloramphenicol | Vancomycin | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0% NaCl | 5% NaCl | 0% NaCl | 5% NaCl | 0% NaCl | 5% NaCl | 0% NaCl | 5% NaCl | 0% NaCl | 5% NaCl | |
| 16 | 8 | 16 | 16 | 8 | 4 | 4 | 1 | 16 | 64 | |
|
| 8 | 4 | 16 | 4 | 8 | 2 | 16 | 2 | 16 | 32 |
| 8 | 4 | 8 | 2 | 8 | 2 | 64 | 1 | 32 | 64 | |
| 8 | 4 | 8 | 2 | 8 | 2 | 16 | 1 | 32 | 64 | |
|
| 4 | 2 | 4 | 2 | 4 | 1 | 32 | 0.5 | 0,5 | 1 |
Fig. 2Appearance of 260-nm-absorbing material in the filtrates of V. cholerae SG24 (1), PC2, NB2 and CO6 after treatment with compounds 1, 2 and 4. Bars represent the mean ± standard deviation of the triplicate OD at each incubation time. At the same incubation time, letters a-d indicate significant differences between samples according to one way ANOVA and Waller Duncan test; p < 0.05
Fig. 3Bacteriolytic effect of compounds 1, 2 and 4 against V. cholerae NB2. Results represent the mean ± standard deviation of the triplicate OD at each incubation time